Genetic Signatures Limited (ASX: GSS)

Genetic Signatures Revenue

In the fiscal year ending June 30, 2024, Genetic Signatures had annual revenue of 13.77M AUD, down -36.00%. Genetic Signatures had revenue of 8.73M in the half year ending June 30, 2024, a decrease of -35.71%.

• Revenue: 13.77M
• Revenue Growth: -36.00%
• P/S Ratio: 7.80
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 147.60M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	13.77M	-7.75M	-36.00%
Jun 30, 2023	21.51M	-13.98M	-39.39%
Jun 30, 2022	35.50M	7.11M	25.06%
Jun 30, 2021	28.38M	14.57M	105.43%
Jun 30, 2020	13.82M	6.79M	96.71%